MENU
+Compare
GCTK
Stock ticker: NASDAQ
AS OF
Apr 24, 04:59 PM (EDT)
Price
$0.16
Change
+$0.01 (+6.67%)
Capitalization
8.11M

GCTK GlucoTrack Inc Forecast, Technical & Fundamental Analysis

GlucoTrack Inc is a medical device company... Show more

GCTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for GCTK with price predictions
Apr 23, 2025

GCTK's RSI Indicator ascends from oversold territory

The RSI Indicator for GCTK moved out of oversold territory on April 23, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 35 similar instances when the indicator left oversold territory. In of the 35 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Momentum Indicator moved above the 0 level on April 23, 2025. You may want to consider a long position or call options on GCTK as a result. In of 114 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GCTK advanced for three days, in of 153 cases, the price rose further within the following month. The odds of a continued upward trend are .

GCTK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GCTK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.441) is normal, around the industry mean (23.728). P/E Ratio (0.000) is within average values for comparable stocks, (81.831). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (41.794).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. GCTK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GCTK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
GCTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
301 Route 17 North
Phone
+1 201 842-7715
Employees
3
Web
https://www.glucotrack.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RGLS2.550.23
+9.70%
Regulus Therapeutics
FBP19.560.90
+4.82%
First BanCorp
CHSN0.290.01
+4.60%
Chanson International Holding
ALB55.640.87
+1.59%
Albemarle Corp
CLW24.06-0.38
-1.55%
Clearwater Paper Corp

GCTK and Stocks

Correlation & Price change

A.I.dvisor tells us that GCTK and QTRX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GCTK and QTRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GCTK
1D Price
Change %
GCTK100%
+6.35%
QTRX - GCTK
32%
Poorly correlated
+3.39%
SIBN - GCTK
30%
Poorly correlated
+1.39%
OCX - GCTK
24%
Poorly correlated
+1.03%
INMD - GCTK
23%
Poorly correlated
-0.32%
PEN - GCTK
23%
Poorly correlated
+0.56%
More